The Analysis Data Model (ADaM) Supplement to version 1.0 of TAUG-Diabetes illustrates using ADaM to create datasets that support analyzing statistical endpoints common to diabetes clinical trials.
TA Standards extend the Foundational Standards to represent data that pertain to specific indications within disease areas. CDISC Standards specify how to structure the data; they do not specify what data should be collected or how to conduct clinical trials, assessments or endpoints.
Public Review Comments
CDISC posts Public Review comments and resolutions to ensure transparency and show implementers how comments were addressed in the standard development process.